ABX-002 is a novel CNS-penetrant TR-B agonist prodrug with potential for treatment of demyelinating disorders as well as other neuroinflammatory and/or neurodegenerative diseases.

This product can not be ordered from your electronic catalog. A quotation will be created for this reference, would you like to continue? In this case, make sure that you have filled in the desired quantity
E-Mail